Home
About Us
Management
Thrust Areas
Disclaimer
Dr Boominathan’s Quotes
Ideas
Bio-Med Ideas
Ideas for Free
Bio-Pharma/Med Ideas
Audience Profile
Bio-Medical Ideas-7,900+
Bio-Med Res Grants Aid
p63 and p73 Community
How p63/p73/p53 Field Progresses
Noble Laureate’s work tracked by GBMD
Ideas were viewed by World’s Best 10 Universities
Submit your Ideas
miRNA Therapeutics
Intellectual Property Development
Licensing Opportunities
Partnerships
Investor opportunities
Educational Tools
Scientific Resources
Research
Research Focus
Research Themes
Research – II
Dr Boomi’s Contributions (Res)
Dr Boomi’s caliber (Sci)
Conference publications
Research Publications
Research Training
Ph.D/M.D/M.Tech Mentor
What Scientists Saying
Peer/Manuscript Review
Press/Media Release
Conferences/Meetings
B-MERIIT
Introduction
Founder
What We Assure
M.S program
M.S in Molecular Cancer Biology
M.S in Stem cell Biology & Regenerative Medicine
M.S in Mol. Medicine
M.S in Genome Biology
M.S in Bio-Medical Sciences
Model Building & Model Laboratory
Investor opportunities
Logo
Career guidance
Admission Details
Registration
Terms and conditions
Career/Opportunities
Contact Us
October
October 24, 2020
Published by
admin_auro
at
October 24, 2020
Categories
Antiviral diseases
Ideas
PTC299-based therapy for COVID-19/SARS-COV-2 and other infectious diseases: PTC299, an anti-cancer drug, inhibits SARS-COV-2, Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, Influenza H1NI1, Foot and Mouth disease, ADV, respiratory syncytial, Sindbis, and SFV viruses and others by increasing the levels of IFN (Interferon)-alpha/alpha-2/beta/gamma/lamda, interferon-inducible transmembrane protein IFITM3, Interferon-stimulated gene-15, Mx2 and antimicrobial peptides and decreasing the expression of inflammatory cytokines 24/October/2020, 9.39 am
Introduction: What they say: A study from the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Charlestown, MA 02129, USA […]
